Transcatheter Reshaping of the Mitral Annulus in Patients with Functional Mitral Regurgitation: One-year Outcomes of the MAVERIC Trial.
CONCLUSION: The ARTO™ transcatheter mitral valve repair system is both safe and effective in decreasing FMR up to one-year post-procedure.
PMID: 32718911 [PubMed - as supplied by publisher]
Source: EuroIntervention - Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research
More News: Cardiology | Cardiovascular & Thoracic Surgery | Gastroschisis Repair | Heart | Heart Attack | Heart Failure | Heart Valve Surgery | Renal Failure | Stroke | Study